Lexicon Pharmaceuticals

Which of These Billion-Dollar Biotechs Is a Buy?

Which of These Billion-Dollar Biotechs Is a Buy?

Motley Fool

Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership

Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership

TheStreet.com

US FDA grants fast track status to Lexicon's LX1033

US FDA grants fast track status to Lexicon's LX1033

Pharmaceutical Business Review

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week

Motley Fool

Lexicon Pharma: Blockbuster Potential From A Diabetes Drug

Lexicon Pharma: Blockbuster Potential From A Diabetes Drug

TheStreet.com

Biotech Weekend Recap: Clinical Trials, Company Files

Biotech Weekend Recap: Clinical Trials, Company Files

Seeking Alpha

Lexicon Pushes On To Phase III

Lexicon Pushes On To Phase III

Seeking Alpha

Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline

Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline

Yahoo/Reuters

Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies

Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies

PharmaLive

Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting

Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting

Yahoo/PR NewsWire